miRdetect
Protecting the privacy of individuals by ensuring that data is processed in a fair and transparent way.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Mirdetect.de operates in the healthcare sector, focusing on the development of diagnostic solutions for testicular cancer. The company serves medical professionals and healthcare institutions by providing advanced prognostic staging systems that aid in the classification and treatment of metastatic germ cell cancers. Mirdetect.de's business model revolves around offering specialized diagnostic tools that enhance the accuracy and efficiency of cancer diagnosis, thereby improving patient outcomes. Revenue is generated through the sale of these diagnostic solutions to hospitals, clinics, and research institutions. The company positions itself as a key player in the niche market of testicular cancer diagnostics, leveraging scientific expertise and innovative technology to address critical needs in cancer care.
Keywords: diagnostic, testicular cancer, prognostic, staging systems, healthcare, germ cell, cancer, medical, solutions, revenue.